Page 57 - Read Online
P. 57

Riachi et al. Mini-invasive Surg 2023;7:14  https://dx.doi.org/10.20517/2574-1225.2022.120  Page 3 of 11

               improved outcomes after 10 LPD cases; however, outcomes may not plateau until 50 cases [22,23] . In 2010, of
                                                                                                       [24]
               the institutions with surgeons that actively performed LPD, only 8% performed at least 10 LPDs per year .
               Therefore, even when a surgeon achieves proficiency with LPD, there may not be a sufficient case volume to
               maintain said proficiency. Second, the outcomes data are equivocal regarding the superiority of LPD
               compared to open PD. Early retrospective studies demonstrated shorter lengths of stay, decreased rates of
               complications, and oncologically safe outcomes [25,26] . Conversely, other studies suggested increased
               morbidity and mortality after LPD [24,27] . Recently, three randomized controlled trials published data
               comparing perioperative outcomes between open PD and LPD [28-30] . The first two published trials (PLOT
               and PADULAP) were single-institution studies, each involving two surgeons, that randomized 64 patients
               (32 LPD and 32 open PD) and 66 patients (34 LPD and 32 open PD), respectively [28,29] . Both studies
               demonstrated shorter lengths of hospital stay and longer operating times with LPD. While both studies
               showed equivalent oncologic outcomes between the two approaches, the PADULAP trial also showed better
               post-operative morbidity outcomes with LPD. Of note, only one patient required conversion to open in the
               PLOT trial, whereas eight patients (23.5%) were converted to an open approach in the PADULAP trial. The
               LEOPARD-2 trial was a multicenter, patient-blinded, randomized phase 2/3 trial involving four high-
               volume centers in the Netherlands . After 99 patients underwent surgery, the study was terminated early
                                             [30]
               due to higher 90-day complication-related mortality in the LPD group (five [10%] vs. 1 [2%]; P = 0.20), and
               no clear demonstrated advantage. There were no significant differences in time to functional recovery,
               Clavien-Dindo grade III or higher complications, or grade B/C POPF between the two approaches. Lower
               annual volume of LPDs at participating institutions during LEOPARD-2 (median 11) may partially explain
               the conflicting results compared to PLOT and PADULAP trials. While these studies provided prospective
               data, the generalizability of the results is limited by low enrollment, varying experience, or high approach
               conversion rates. A 2020 systematic review and meta-analysis of these randomized controlled trials revealed
               no statistically significant differences between either PD approach regarding the length of stay, post-
               operative complications, and mortality . As it stands, LPD remains the dominant minimally invasive
                                                 [31]
               approach in areas where cost and availability limit alternative minimally invasive approaches.


               ROBOTIC SURGERY
               Dr. Kwoh performed the first robotic/computer-assisted surgery, a brain biopsy, with the PUMA 560 in
               1985 . Private and government collaborations over the next decade led to many advances in robotic
                   [32]
               technology, culminating in Mona (Intuitive®), the first robotic surgical system to move to human trials. In
               1997, Dr. Himpens, with Dr. Cardiere at the bedside operating the endoscopic camera, performed a
               cholecystectomy using the Mona robotic surgical system . Despite the early success of the Mona system,
                                                                [33]
               certain limitations prohibited further implementation, which then informed the development of the da
               Vinci robotic system. Since receiving FDA approval for abdominal surgeries in July 2000, da Vinci iterations
               have expanded across the globe . Their global reach even includes real-time tele-surgery, as was
                                            [34]
               demonstrated in 2001 when a New York-based surgeon performed a tele-robotic cholecystectomy on a
                                       [35]
               patient in Strasbourg, France .
               Robotic surgery has multiple advantages compared to laparoscopic surgery. First, the instruments move in
               the same direction as the surgeon’s hand, providing strong hand-eye coordination. As a result, the
               instruments more accurately function as an extension of the surgeon’s hands rather than a device needing
               counterintuitive movements to get the desired effect. Second, the robotic platform eliminates physiologic
               tremors, both for the instruments and the camera, and provides greater degrees of freedom than the human
               hand. This allows for fine, precise movements performed with a greater range of motion. Third, the surgeon
               can have immediate control of up to three instruments. The surgeon also maintains control of the camera
               throughout the operation. Furthermore, the robotic camera uses a 3D high-definition camera with superior
   52   53   54   55   56   57   58   59   60   61   62